Figure 2.

Kaplan‐Meier plots for survival by CS status and reason for initial unresectability. A. Overall survival by CS. Patients who completed CS had significantly longer MS than those who did not (44.1 vs 14.5 months, P < 0.0001). B. Disease‐free survival of patients with CS from time of initial treatment and time of CS, respectively. Median duration from CS to initial recurrence was estimated to be 18.7 months. Median duration from initial treatment to initial recurrence was estimated to be 29.0 months. C. Overall survival of patients with CS stratified by initial UR‐LA status. MS of patients with initial UR‐LA‐PC who completed CS was 41.4 months, significantly longer than in patients who did not undergo surgery (16.9 months, P = 0.00002). D. Overall survival of patients with CS stratified by initial UR‐M status. MS of patients with initial UR‐M‐PC who completed CS was not reached, compared with 14.4 months in those without surgery. ( | ) denotes a censored case. CS, conversion surgery; FCS, from the time of CS; FIT, from initial treatment; LA, locally advanced; M, metastatic; MS, median survival; PC, pancreatic cancer; UR, unresectable